MiMedx Group, Inc. Proceeds from Issuance of Secured Debt
MiMedx Group, Inc. (MDXG) reported Proceeds from Issuance of Secured Debt of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSecuredDebt · last filed 2026-02-25
- MiMedx Group, Inc. proceeds from issuance of secured debt for the quarter ending 2025-12-31 was $0.00.
- MiMedx Group, Inc. proceeds from issuance of secured debt for the quarter ending 2025-09-30 was $0.00.
- MiMedx Group, Inc. proceeds from issuance of secured debt for the quarter ending 2025-06-30 was $0.00.
- MiMedx Group, Inc. proceeds from issuance of secured debt for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- MiMedx Group, Inc. proceeds from issuance of secured debt for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- MiMedx Group, Inc. proceeds from issuance of secured debt for fiscal 2024 was $19.78M.
- MiMedx Group, Inc. proceeds from issuance of secured debt for fiscal 2023 was $0.00.
- MiMedx Group, Inc. proceeds from issuance of secured debt for fiscal 2022 was $0.00.
| Period end | Proceeds from Issuance of Secured Debt 3 month | Proceeds from Issuance of Secured Debt 6 month | Proceeds from Issuance of Secured Debt 9 month | Proceeds from Issuance of Secured Debt 12 month | Proceeds from Issuance of Secured Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $0.00 derived: sum of 2 quarters · filed 2025-10-29 | $0.00 10-Q · filed 2025-10-29 | $0.00 derived: sum of 4 quarters · filed 2026-02-25 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $0.00 10-Q · filed 2025-07-30 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 derived: sum of 4 quarters · filed 2026-02-25 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-04-30 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $19.78M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $0.00 derived: sum of 2 quarters · filed 2025-10-29 | $19.78M 10-Q · filed 2025-10-29 | $19.78M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $19.78M 10-Q · filed 2025-07-30 | $19.78M derived: sum of 3 quarters · filed 2026-02-25 | $19.78M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | $19.78M 10-Q · filed 2025-04-30 | $19.78M derived: sum of 2 quarters · filed 2026-02-25 | $19.78M derived: sum of 3 quarters · filed 2026-02-25 | $19.78M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $0.00 derived: sum of 2 quarters · filed 2024-10-30 | $0.00 10-Q · filed 2024-10-30 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $0.00 10-Q · filed 2024-07-31 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-04-30 | ||||
| 2022-12-31 | $0.00 10-K · filed 2025-02-26 | ||||
| 2013-12-31 | $0.00 10-K · filed 2014-03-04 | ||||
| 2012-12-31 | $0.00 10-K · filed 2014-03-04 | $1.25M 10-K · filed 2013-03-15 | |||
| 2011-12-31 | $1.25M 10-K · filed 2014-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |